Literature DB >> 12762135

An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians.

Toshiyuki Yamada1, Yasuaki Okuda, Kiyoshi Takasugi, Lishan Wang, Duane Marks, Merrill D Benson, Barbara Kluve-Beckerman.   

Abstract

Serum amyloid A1 (SAA1), one of the two isotypes of acute phase SAA, is the predominant precursor to amyloid A (AA) protein, the chief constituent of fibrillar deposits in reactive (AA) amyloidosis. Prolonged hyperexpression of SAA protein accompanying chronic inflammation is critical to, but seems not to be sufficient for, the development of AA amyloidosis. Several previous studies have investigated the possibility of linkage between SAA1 exon 3 polymorphisms and susceptibility to amyloidosis. While the SAA1.1 allele was found to have a negative association with amylodosis in Japanese subjects, it showed a positive association in Caucasians. Moriguchi and colleagues recently showed that a single nucleotide polymorphism (SNP) at position -13 in the SAA1 5' flanking region was more strongly associated with amyloidosis than was the exon 3 polymorphism. To test whether this SNP may be an amyloidogenic factor common to Japanese and Caucasians, we have analyzed the SAA1 gene in amyloid and non-amyloid patients of both ethnic groups for the presence of T or C at position -13 and for exon 3 polymorphisms (SAA1.1, 1.3 or 1.5). The frequency of the -13T allele was 0.708 and 0.521 in Japanese rheumatoid arthritis patients with and patients without AA amyloidosis, respectively, and 0.536 and 0.196 in American Caucasian patients with AA amyloidosis and control subjects, respectively. In Caucasians, the -13T allele had a stronger association with amyloidosis than did the SAA1.1 allele. These findings suggest that -13T is a genetic background for AA amyloidosis in both Japanese and Caucasians and the difference in prevalence of AA amyloidosis in the two ethnic groups may be due, at least in part, to a difference in the frequency of the -13T SAA1 allele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762135     DOI: 10.3109/13506120308995250

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  10 in total

1.  Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.

Authors:  Mingjie Chen; Huibing Zhou; Ni Cheng; Feng Qian; Richard D Ye
Journal:  Immunobiology       Date:  2014-08-10       Impact factor: 3.144

2.  Test of association between haplotypes and phenotypes in case-control studies: examination of validity of the application of an algorithm for samples from cohort or clinical trials to case-control samples using simulated and real data.

Authors:  Shiori Furihata; Toshikazu Ito; Naoyuki Kamatani
Journal:  Genetics       Date:  2006-09-15       Impact factor: 4.562

Review 3.  New advances in renal amyloidosis.

Authors:  Shinichi Nishi; Bassam Alchi; Nofumi Imai; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

4.  Systemic Amyloid A Amyloidosis in Island Foxes (Urocyon littoralis): Severity and Risk Factors.

Authors:  P M Gaffney; C Witte; D L Clifford; D M Imai; T D O'Brien; M Trejo; F Liberta; K Annamalai; M Fändrich; E Masliah; L Munson; C J Sigurdson
Journal:  Vet Pathol       Date:  2015-09-29       Impact factor: 2.221

5.  Fluorescent quenching probes based SAA 1 genotyping with a fully automated system.

Authors:  Jie Zhang; Changgen Shi; Lei Zhang; Yan Zhang; Qing Lu; Rongfang Wang
Journal:  Heliyon       Date:  2021-04-27

6.  The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population.

Authors:  Kiyoshi Migita; Kazunaga Agematsu; Junya Masumoto; Hiroaki Ida; Seiyo Honda; Yuka Jiuchi; Yasumori Izumi; Yumi Maeda; Ritei Uehara; Yoshikazu Nakamura; Tomohiro Koga; Atsushi Kawakami; Munetoshi Nakashima; Yuichiro Fujieda; Fumiaki Nonaka; Katsumi Eguchi; Hiroshi Furukawa; Tadashi Nakamura; Minoru Nakamura; Michio Yasunami
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  SAA1 alpha/alpha alleles in Behçet's disease related amyloidosis.

Authors:  Umut Utku; Melda Dilek; Ilkser Akpolat; Abdülkerim Bedir; Tekin Akpolat
Journal:  Clin Rheumatol       Date:  2006-10-13       Impact factor: 3.650

8.  Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease.

Authors:  Makiko Yashiro; Hiroshi Furukawa; Tomoyuki Asano; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Eiji Suzuki; Tadashi Nakamura; Tomohiro Koga; Toshimasa Shimizu; Masataka Umeda; Fumiaki Nonaka; Yukitaka Ueki; Katsumi Eguchi; Atsushi Kawakami; Kiyoshi Migita
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling.

Authors:  Huikai Zhang; Yang Xu; Gang Deng; Fanen Yuan; Yinqiu Tan; Lun Gao; Qian Sun; Yangzhi Qi; Kun Yang; Rongxin Geng; Hongxiang Jiang; Baohui Liu; Qianxue Chen
Journal:  J Cancer       Date:  2021-03-10       Impact factor: 4.207

10.  Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.

Authors:  Meina Tei; Kazuyuki Uchida; James K Chambers; Ken-Ichi Watanabe; Takashi Tamamoto; Koichi Ohno; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2017-12-04       Impact factor: 1.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.